Search for content, post, videos

Immunovia Inc achieves Clinical Laboratory Licensure

Jeff Borcherding

The Rhode Island Department of Health has granted Immunovia, Inc., the US subsidiary of Immunovia, Clinical Laboratory licensure.

The licensure allows physicians in Rhode Island to order the IMMray PanCan-d test for their patients.

“Receiving licensure in Rhode Island now allows us to offer IMMray PanCan-d in 46 states. We expect additional state licensures to follow, as we work to make IMMray PanCan-d accessible to patients across the United States who are at risk for pancreatic cancer,” says Jeff Borcherding, Chief Executive Officer of Immunovia, Inc.

Photo of Jeff Borcherding